Pasireotide to Reduce Clinically Relevant Digestive Leakage After Complete Cytoreductive Surgery (CRS) Plus Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis
Clinical trial NCT04826432 · TERMINATED
Trial details
- NCT number
- NCT04826432
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-03
- Primary completion
- 2024-02-07
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.